Oral drug Molnupiravir effective against COVID-19
The scientists from the National Institutes of Health (NIH) in the US and the University of Plymouth in the UK stated that MK-4482 also called as Molnupiraviru was effectively working when it provided up to 12 hours before and 12 hours after the Coronavirus infection. It is said that this orally administered drug developed to treat influenza and it also decreasing novel Coronavirus levels in hamsters said, researchers.
The study stated that the drug also decreasing the damage causes to the lungs and the study was conducted on hamsters. Researchers said that it increasing confidence to bring out a pill to fight against the Coronavirus.